Ciencias de la vida

MICRODIALYSIS DEVICE
21/05/2026 - The present invention relates to a microdialysis device comprising a tube and a duct that are connected by means of a connector, thereby improving substance distribution as well as sample...
Plant material squeezing solid-liquid separation device capable of preventing filter screen from slagging
06/03/2026 - The invention discloses a plant material squeezing solid-liquid separation device capable of preventing a filter screen from slagging, and particularly relates to the technical field of...
Expanding material compression equipment and application method thereof
06/03/2026 - The invention discloses expansion material compression equipment and an application method thereof, and relates to the field of medicament production.The expansion material compression equipment...
Whole-course closed preparation system and method for high-activity medicine solid tablets
03/02/2026 - The invention provides a whole-course closed preparation system and method for high-activity medicine solid tablets, and the system comprises a material inlet module, an auxiliary material...
Rotary tablet press with tablet outlet and use method of rotary tablet press
09/01/2026 - The invention belongs to the technical field of tablet production, and discloses a rotary tablet press with a tablet outlet, which comprises a shell, and further comprises a base fixedly connected...
Intelligent cruise garbage picking and classifying vehicle, method, equipment and medium
11/07/2025 - The invention provides an intelligent cruise garbage picking and classifying vehicle, method, equipment and medium to solve the problem that in the prior art, a laser radar can only obtain...
IMMUNOCONJUGATES FOR NCAM1 AND METHODS OF USE
04/06/2026 - Provided herein are anti-NCAMl antibodies and anti-NCAMl immunoconjugates. Such anti-NCAMl antibodies and anti-NCAMl immunoconjugates can be used for treating cancer.
VIRAL VECTORS FOR EXPRESSION OF SYNTHETIC CANCER ANTIGENS AND CHEMOKINE AND RELATED METHODS AND USES
04/06/2026 - The present disclosure generally relates to a viral vector carrying a synthetic cancer antigen and a chemokine. Also provided herein are compositions and uses of the viral vector for delivering,...
IMMUNOCONJUGATES FOR SEZ6L2 AND METHODS OF USE
04/06/2026 - Provided herein are anti-SEZ6L2 immunoconjugates that can be used for treating cancer.
CLAUDIN 18.2 ANTIBODIES, ANTIGEN BINDING FRAGMENTS AND ANTIBODY DRUG CONJUGATES THEREOF AND METHODS OF USE IN CANCER THERAPY
04/06/2026 - Provided are antibodies, antigen binding fragments, and immunoconjugates thereof that specifically bind to claudin 18.2 expressing cells, along with pharmaceutical compositions and kits comprising...
COMBINATION THERAPY FOR THE TARGETED DEGRADATION OF BCL6
04/06/2026 - The present disclosure relates to methods of treating cancer in a subject, comprising administering to the subject an effective amount of Compound A, or a pharmaceutically acceptable salt thereof...
SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENE DERIVATIVES AS KRAS INHIBITORS FOR THE TREATMENT OF CANCER
04/06/2026 - The present invention encompasses compounds of formula (I) the compounds of formula (I) for use as inhibitors of KRAS, pharmaceutical compositions and preparations containing such compounds and...
COMBINATION THERAPY FOR THE TARGETED DEGRADATION OF BCL6
04/06/2026 - The present disclosure relates to methods of treating cancer in a subject, comprising administering to the subject an effective amount of Compound A, or a pharmaceutically acceptable salt thereof,...
METAL-BASED ANTI-CANCER COMPLEX
04/06/2026 - A metal complex comprising: (a) a pharmaceutically acceptable central metal; (b) a DNA methyltransferase (DNMT) inhibitor; and (c) 2,5-dihydroxyterephthalic acid (DTA) and/or syringic acid...
CANCER
04/06/2026 - The invention relates to cancer therapy, and in particular, to novel polypeptides derived from the oncogenic transcription factor c-MYC (MYC), conjugates thereof, pharmaceutical compositions...
COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF IN PREPARATION OF DRUGS FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
08/05/2026 - The present invention relates to the technical field of medicine, and discloses a compound, a pharmaceutical composition, and a use thereof in preparation of drugs for treating cardiovascular and...
TARGETED PROTEIN DEGRADATION
15/05/2026 - This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof) that degrade and/or otherwise modulate (e.g., inhibit) NIMA Related Kinase 7 (NEK7)....
PHARMACEUTICAL COMPOSITION FOR PROMOTING MIGRATION OF SUBSTANCE TO CENTRAL NERVOUS SYSTEM
15/05/2026 - Provided is a composition for promoting migration of a target substance to the central nervous system, the composition containing a substance having an inhibitory activity against sphingomyelin...
TREATMENT OF POST-ACUTE INFECTION SYNDROMES SUCH AS LONG COVID AND RELATED SYMPTOMS
15/05/2026 - The present invention relates to the field of medicine. The invention in particular relates to amide- derivatives of 2-hydroxy-2-methyl-4-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-butanoic acid and...
COMPOSITIONS AND METHODS FOR THE TREATMENT OF TAU-RELATED DISORDERS
15/05/2026 - The disclosure provides compositions and methods for the preparation, manufacture and use of an adeno-associated virus (AAV) particle for the vectorized delivery of an antibody molecule that binds...
INTRANASAL APPLICATION OF MESENCHYMAL STEM CELLS IN THE THERAPY OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY
20/05/2026 - The invention relates to mammalian mesenchymal stem cells (MSCs) for use in a method of treatment of a hypoxic-ischemic brain injury (HIBI) event in a human neonate. Particular routes of...